The content on this site is intended for healthcare professionals only
Dr Sanjit Agrawal speaks to ecancer about the oncologic safety of breast conservation following NACT in women with locally advanced breast cancer.
He says that this study is a retrospective observational study of 411 non-metastatic locally advanced breast cancer (LABC) patients who received neoadjuvant chemotherapy (NACT) followed by surgery from 2011 to 2016.
The study found that BCS is technically feasible in LABC patients.
Dr Agrawal concludes that LABC patients who respond well to NACT can be offered BCS without compromising survival outcomes.
Read the full study here.
Laser oncosurgery - A new perspective in treating cancer
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer
Comment: EBCC 2024 highlights
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
SABCS 2023: Highlights
Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients
Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer
